je.st
news
Tag: results announces
WestRock Announces Final RockTenn Shareholder Merger Consideration Election Results
2015-07-03 05:39:19| Paper - Topix.net
WestRock Company today announced the final results of the elections made by former RockTenn shareholders as to the form of merger consideration they wished to receive in connection with the combination of Rock-Tenn Company and MeadWestvaco Corporation into WestRock.
Tags: results
final
consideration
election
EMCORE Corporation Announces Final Results of Its Modified Dutch...
2015-06-20 21:06:42| Semiconductors - Topix.net
EMCORE Corporation today announced the final results of its modified "Dutch auction" tender offer, which expired at 5:00 P.M., New York City time, on June 15, 2015. The Company today accepted for purchase 6,870,229 shares of EMCORE common stock at a purchase price of $6.55 per share, for a total aggregate cost of approximately $45 million, excluding fees and expenses related to the tender offer.
Tags: results
final
modified
corporation
Aimmune Therapeutics Announces Positive Phase 2 Study Results Of AR101 For The Treatment Of Peanut Allergy
2015-06-17 06:39:17| foodingredientsonline Home Page
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced recently that a Phase 2 study (ARC001) evaluating the company’s lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively
Tags: of
results
study
positive
Thor Industries (THO) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS
2015-06-05 02:54:31| Mobile Homes - Topix.net
Thor Industries issued its quarterly earnings data on Thursday. The company reported $1.19 earnings per share for the quarter, missing the analysts' consensus estimate of $1.20 by $0.01, Market Beat Ratings reports.
Tags: results
industries
expectations
quarterly
Enanta Announces SVR12 Results Of 95% From AbbVie's GIFT-1 Study In Non-Cirrhotic, Japanese Patients With Genotype 1b Hepatitis C Virus1
2015-06-03 06:35:57| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced recently that new data from AbbVie’s phase 3 GIFT-I study, its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir, was presented at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan
Tags: c
results
study
japanese
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »